首页> 外文期刊>Current pharmaceutical design >Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy.
【24h】

Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy.

机译:靶向超声造影剂的研究进展及其在分子成像和靶向治疗中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

In recent years, targeted ultrasound contrast agents (UCA) have emerged with the rapid development of contrast-enhanced ultrasound technology and bio-nanotechnology, showing good prospects for applications in molecular imaging and targeted therapy. The non-invasive treatment modality can reduce the drug dosage, toxicity and side effects, providing a new kind of methodology and approach for treatments, which will greatly expand the research and its applications. Targeted UCA have been developed rapidly in recent years, and a variety of new UCA appear, such as multi-functional UCA, multi-modal UCA, UCA with double ligands or more ligands, long-circulating UCA and immune type UCA, which meet growing clinical and research needs. The novel UCA have made a great progress and play an increasingly important role in molecular imaging. In this article, we reviewed the concepts of ultrasound molecular imaging, and summarized the applications of targeted UCA in molecular imaging and targeted therapy.
机译:近年来,随着超声增强超声技术和生物纳米技术的飞速发展,靶向超声造影剂(UCA)出现了,在分子成像和靶向治疗中的应用前景良好。无创治疗方式可以减少药物用量,毒性和副作用,为治疗提供了一种新的方法论和方法,将大大扩大研究范围和应用范围。靶向UCA近年来发展迅速,并且出现了许多新的UCA,例如多功能UCA,多峰UCA,具有双配体或更多配体的UCA,长循环UCA和免疫型UCA,它们不断发展临床和研究需求。新型UCA取得了长足的进步,并在分子成像中起着越来越重要的作用。在本文中,我们回顾了超声分子成像的概念,并总结了靶向UCA在分子成像和靶向治疗中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号